MUMBAI, India, March 14 -- Intellectual Property India has published a patent application (202517130940 A) filed by Gmp Biotechnology Limited, Hong Kong, on Dec. 23, 2025, for 'anti-cancer tgfb2 agents with immunotherapeutics.'
Inventor(s) include Trieu, Vuong.
The application for the patent was published on March 13, under issue no. 11/2026.
According to the abstract released by the Intellectual Property India: "This invention relates to methods for treating or ameliorating the symptoms of cancer in a human or animal subject with pharmaceutical compositions designed to promote anti-tumor effects. Exemplary synergistic pharmaceutical therapies include compositions having a combination of active agents including agents for inhibiting or s...